| Ytd | -41.97% | |
| 1y | -36.91% |
| Open | 2.56 | Prev Close | 2.53 | Low | 2.50 | High | 2.56 | Mkt Cap | 114.47M |
| Vol | 143.12K | Avg Vol | 275.80K | EPS | -0.86 | P/E | N/A | Forward P/E | -2.45 |
| Beta | 0.57 | Short Ratio | 8.90 | Inst. Own | 15.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-06 | 50-d Avg | 2.73 | 200-d Avg | 2.95 | 1yr Est | 18.40 |
Gainers EXoZymes (NASDAQ:EXOZ) stock increased by 7.5% to $7.18 during Wednesday's after-market
-- A platinum-relapsed SCLC patient achieved 16.7 months progression-free survival following Olvi-Ve
Gainers iSpecimen (NASDAQ:ISPC) shares increased by 10.4% to $1.7 during Friday's after-market
Genelux (NASDAQ:GNLX) reported quarterly losses of $(0.21) per share which missed the analyst consen
-- Topline data from Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expec
Genelux (NASDAQ: GNLX - Get Free Report) is expected to post its Q2 2026 results before the market o
- Findings provide mechanistic support for previously reported clinical outcomes of clinical reversa
- Findings provide mechanistic support for previously reported clinical outcomes of clinical reversa
-- Topline data from randomized Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi
-- Topline data from Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expect
WESTLAKE VILLAGE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la
WESTLAKE VILLAGE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq:
WESTLAKE VILLAGE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq:
WESTLAKE VILLAGE, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a l
-- Lung cancer programs progressing with interim data updates expected in Q4 2025 -- -- Topline data
WESTLAKE VILLAGE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la
WESTLAKE VILLAGE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la
Genelux Corporation (GNLX) might move higher on growing optimism about its earnings prospects, which
WESTLAKE VILLAGE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a lat
– Alignment reached with U.S. Food and Drug Administration on key elements of the approval pathway f
Genelux Corporation (GNLX) is technically in oversold territory now, so the heavy selling pressure m
WESTLAKE VILLAGE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq
WESTLAKE VILLAGE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la
WESTLAKE VILLAGE, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la
Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarte
Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quar
Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Tuesday. Here are some bi
U.S. stocks traded down this morning, with the Nasdaq Composite falling more than 101 points on Frid
Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 8
Gainers Unique Fabricating, Inc. (NYSE: UFAB) shares jumped 113% to $0.4605 after gaining 12% on
Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.
In a year that’s seen a sharp decline in initial public offerings, Washington, D.C.-based Mediterran
U.S. stocks traded lower, with the Dow Jones dropping more than 250 points on Thursday. Here are som
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announ
U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Friday. Here are some big st